Monday, August 21, 2017
 
 
Company News: Page (1) of 1 - 02/16/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Nu Skin Enterprises Announces Dividend Increase
 
(February 16, 2017)

PROVO, Utah, Feb. 16, 2017 /PRNewswire/ -- Nu Skin Enterprises, Inc.(NYSE: NUS) today announced its board of directors has increased the quarterly cash dividend to $0.36 from the previous $0.355 per share. The quarterly dividend will be paid on March 15, 2017, to stockholders of record on Feb. 27, 2017.

"This marks the 16th consecutive year of raising our dividend, demonstrating our ongoing commitment to create shareholder value," saidTruman Hunt, president and chief executive officer.


About Nu Skin Enterprises, Inc.

Founded more than 30 years ago, Nu Skin Enterprises, Inc. develops and distributes innovative consumer products, offering a comprehensive line of premium-quality beauty and wellness solutions. The company builds upon its scientific expertise in both skin care and nutrition to continually develop innovative product brands that include the Nu Skin personal care brand, the Pharmanex nutrition brand, and most recently, the ageLOC anti-aging brand. The ageLOC brand has generated a loyal following for such products as the ageLOC Youth nutritional supplement, the ageLOC Me customized skin care system, as well as the ageLOC TR90 weight management and body shaping system. Nu Skin sells its products through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific. As a long-standing member of direct selling associations globally, Nu Skin is committed to the industry's consumer guidelines that protect and support those who sell and purchase its products through the direct selling channel. Nu Skin is also traded on the New York Stock Exchange under the symbol "NUS." More information is available at nuskin.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nu-skin-enterprises-announces-dividend-increase-300409118.html

SOURCE Nu Skin Enterprises, Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords: Inc.,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Medical Sector Contract Electronic Manufacturing Market shows lucrative growth CAGR of 8.8 % by 2022
  • Global Contrast Injector Market Will Reach USD 889.3 Million by 2022: Zion Market Research
  • Ascension Teams with Plug and Play Tech Center to Connect with Health and Wellness Startups
  • Global Sleep Apnea Devices Market to Grow at a CAGR of 7.8% by 2024 - Large Scale Benefits of Medical Devices is Driving Demand for Medical Platforms.
  • At 8+% CAGR Lateral Flow Assay Market Potentially Worth $8.24 Billion by 2022 Led by Asia-Pacific Region

    Cancer
  • Gaucher Disease Market Is Anticipated To Witness Growth Owing To Increasing R&D Activities And Special Facility For Orphan Drugs Till 2021 | Million Insights
  • Astronauts Showcase Space Art Created with Childhood Cancer Patients
  • Three Grant Funding Opportunities for Brain Tumor Research Funding Open Today
  • argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017
  • Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines